Two Sigma Securities, LLC Vertex Pharmaceuticals Inc Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

A detailed history of Two Sigma Securities, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Securities, LLC holds 4,205 shares of VRTX stock, worth $1.95 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,205

Previous 4,900 14.18%

Holding current value

$1.95 Million

Previous $2.3 Million 14.85%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $467,360 - $513,872	-1,016 Reduced 19.46%	4,205 $1.96 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $498,475 - $616,137	1,269 Added 32.11%	5,221 $2.45 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $13 Million - $14.3 Million	-31,956 Reduced 88.99%	3,952 $1.65 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $10.3 Million - $12.3 Million	29,973 Added 505.02%	35,908 $14.6 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $1.57 Million - $1.68 Million	4,647 Added 360.79%	5,935 $2.06 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $404,972 - $453,260	1,288 New	1,288 $453,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $258,041 - $290,296	903 New	903 $260,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $5.4 Million - $6.73 Million	-22,994 Reduced 94.61%	1,309 $369,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $4.11 Million - $4.84 Million	18,557 Added 322.96%	24,303 $6.34 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $788,579 - $995,469	4,455 Added 345.08%	5,746 $1.26 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $43,170 - $48,311	-238 Reduced 15.57%	1,291 $234,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $268,918 - $313,461	-1,299 Reduced 45.93%	1,529 $329,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $386,073 - $514,907	1,865 Added 193.67%	2,828 $668,000
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $163,104 - $193,377	-638 Reduced 39.85%	963 $262,000
Q2 2020 Sep 10, 2020	SELL	$225.48 - $295.8 $1.71 Million - $2.25 Million	-7,600 Reduced 82.6%	1,601 $465,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $1.83 Million - $2.4 Million	8,108 Added 741.81%	9,201 $2.67 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $182,214 - $244,733	1,093 New	1,093 $239,000
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $476,082 - $535,825	-2,864 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $209,713 - $242,531	1,274 Added 80.13%	2,864 $525,000
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $1.33 Million - $1.69 Million	-8,769 Reduced 84.65%	1,590 $263,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $888,465 - $1.02 Million	-5,297 Reduced 33.83%	10,359 $2 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $2.28 Million - $2.66 Million	15,656 New	15,656 $2.66 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account

Two Sigma Securities, LLC Vertex Pharmaceuticals Inc Transaction History